Data as of 3:59pm ET
| -0.06 / -5.22%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +725.69% increase from the last price of 1.09.
The current consensus among 1 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.